Breast Imaging Equipment Market By Product (Mammography Systems, Breast Ultrasound Systems, Breast MRI Systems, Nuclear Imaging Systems, Tomosynthesis Equipment, Biopsy Systems, and Others), By Application (Screening, Diagnosis, Pre-surgical Planning, and Treatment Monitoring), By Technology (Ionizing Breast Imaging Technology and Non-ionizing Breast Imaging Technology), By Modality (Portable Devices and Stationary Equipment), and By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Specialty Clinics, Breast Care Centers, Academic and Research Institutes, and Post-treatment Surveillance), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Jun 2025 | Report ID: MI2991 | 210 Pages
Industry Outlook
The Breast Imaging Equipment market accounted for USD 4.27 Billion in 2024 and USD 4.52 Billion in 2025 is expected to reach USD 7.99 Billion by 2035, growing at a CAGR of around 5.86% between 2025 and 2035. The breast imaging equipment market can be defined as the global market dealing with the research, production, and sale of medical equipment that helps diagnose and treat such diseases as breast cancer by helping to detect, diagnose, and monitor the condition. These involve the mammography systems, breast ultrasound, MRI, tomosynthesis, and molecular breast imaging. The market rides on the back of increased cases of breast cancer, heightened consciousness of early detection, and the development of imaging technologies. The government programs and screening initiatives are also important in market expansion. The low cost of entry into emerging markets and trends in the digital image market also present major growth opportunities.
Industry Experts Opinion
"With 87% of U.S. mammography centers now offering 3D systems, this technology is becoming the standard of care—it reduces callbacks and improves cancer detection, representing a better test overall."
- Dr. Stamatia Destounis, Radiologist and Chair of the ACR Breast Commission
"AI‑enhanced mammography software, like CureMetrix, can support radiologists by improving detection accuracy and reducing unnecessary interventions, which is vital given that nearly 45% of U.S. breast cancers are diagnosed at later stages."
- Kevin Harris, CEO of CureMetrix
Report Scope:
Parameter | Details |
---|---|
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2024 |
Market Size in 2024 | USD 4.27 Billion |
CAGR (2025-2035) | 5.86% |
Forecast Years | 2025-2035 |
Historical Data | 2018-2024 |
Market Size in 2035 | USD 7.99 Billion |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South Africa |
What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and 10 companies. |
Segments Covered | Product, Application, Technology, Modality, End User, and Region |
To explore in-depth analysis in this report - Request Sample Report
Market Dynamics
Rising breast cancer cases drive diagnostic imaging equipment demand upward.
The increasing rate of breast cancer is one of the major factors that will stimulate the increase in demand for imaging equipment for breasts all over the world. The World Health Organisation (WHO) noted that in 2021, there were more than 2.3 million cases of breast cancer recorded each year, making it the most commonly detected malignancy in the world.
The early detection process is crucial, as the survival rate is over 90 per cent when the disease is detected early enough, and the government is increasing screening schemes. In the United States, the Centers for Disease Control and Prevention (CDC) indicated that 65% of mammograms among women aged 50 to 74 have undergone a mammogram in the past 2 years, indicating the popularity of the imaging in routine care.
Moreover, the rate of equation diffusion to newer technologies like 3D mammography (digital breast tomosynthesis) is on the rise because of increased accuracy of detection, which just increases the demand for equipment even more. Awareness programmes through education and public health programmes are still going on, and this adds to screening prevalence and resources in diagnostic instruments.
Growing awareness programs promote regular screenings and diagnostic checkups.
The breast imaging equipment market is fuelled by the increasingly popular awareness campaigns in the population that focus on early detection of breast cancer with the help of regular checkups and diagnostic screening. Government efforts, including the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) offered by the CDC, have been imperative in making breast cancer screening services available to more than 6 million women since its launch. Moreover, the World Health Organisation (WHO) develops the early detection strategies to be used globally and in low- and middle-income countries to minimise mortality rates.
In the United States, the National Cancer Institute shares that the relative survival of breast cancer is 99% within five years in case the cancer is diagnosed early. Improvements in technology, growth of infrastructure in the healthcare sector, enhancement of health awareness among females, and being spurred by growth in education and awareness/advocacy programmes fuel the need for advanced imaging tools, such as 3D mammography and ultrasound. All these are adding up greatly to the sustained expansion of the breast imaging equipment market.
Limited availability of skilled professionals affects equipment utilization rates.
Lack of professionals capable of operating and interpreting the scans is a major cause of under-utilisation of the breast imaging equipment. There is about an 18-20% vacancy rate in England for specialist mammographers, which has a direct impact on the delay of crucial diagnoses. The shortage in India is even steeper: there are barely 20000 radiologists for the 1.4 billion national population, which is equivalent to one radiologist serving one scan per 100,000 population per day. This logistics is a setback to the effective usage of breast mammography practices on a timely basis since the equipment lies idle with no qualified personnel to do the work. The gap is further widened in underprivileged and rural areas where the imaging centres cannot use the machines fully owing to a shortage of technicians.
Indicatively, screening is done on a very low percentage of Indian ladies above the age of 45, a figure that is lower than the average percentage in the world, and this is because of the capability to acquire the necessary professionals required to perform screening. It therefore happens that high-valued imaging systems remain idle or underutilised, which increases the cost of operations and diminishes the returns on investments. To enhance the use of this equipment and early detection of breast cancer, these workforce pressures must be addressed by intervening in the form of training programmes, incentive systems, and expanding tele-radiology.
Expansion in emerging markets offers untapped customer base for imaging.
The low screening rates, which are coupled with the increasing cases of breast cancer, provide a huge potential to manufacturers of breast imaging equipment relevant in the emerging markets. Women in most low- and middle-income countries have a history of having fewer in the range of 20-25% receiving any mammography or clinical breast exams, with even smaller percentages undertaking regular breast self-exams. As an example, less than 2% of women aged 45 years and above have mammograms in India, indicating a huge, underserved women's mass.
Almost 39% of all cancers in those areas are breast cancers, and more than 200,000 new cases of breast cancer are arising each year, but there is a lack of infrastructure for the screenings, particularly in the countryside. This disparity forms a need to produce portable and digital mammography units and hand-held ultrasound machines, which can reach populations that are not equipped with a fixed imaging depot.
The governments are helping facilitate the screening by establishing nationwide screening and mobile health units, which are indications that the market will expand, and the affordable and low-cost breast imaging equipment. The breast imaging market is largely growing in the emerging economies due to the spread of awareness and activities in connection with the need to promote health.
Increasing investments in healthcare infrastructure support equipment deployment growth.
Rising expenditure on healthcare infrastructures is contributing to the expansion of the breast imaging equipment market. Growing emphasis on early-onset detection of cancer by governments around the world is paying a larger interest to improved screening programmes; the resultant effect is an escalated demand for the deployment of advanced imaging facilities such as digital mammography, ultrasound, and MRI. An example would be a condition referred to as breast cancer. As shown by the World Health Organisation (WHO), breast cancer is ranked as the number-one cancer that occurs in women worldwide, yet early detection increases the survival rates by up to 90 per cent.
According to the U.S. National Cancer Institute, the energy in the medical sector, accompanied by government-funded awareness programmes and the provision of diagnostic infrastructures, has led to the continued rise of breast cancer screening in the country. Moreover, educational institutions are leading in the research and training on breast imaging, where there has been the adoption of the most advanced equipment in clinical practice. Access is further increased by investing in underdeveloped and rural areas, stimulating market demand. Such a merger of the field of public health and the improvement of infrastructures offers a strong possibility of the breast imaging equipment business expanding and further developing.
Segment Analysis
Based on the product, the Breast Imaging Equipment market is classified into Mammography Systems, Breast Ultrasound Systems, Breast MRI Systems, Nuclear Imaging Systems, Tomosynthesis Equipment, Biopsy Systems, and Others. Mammography systems are found to be the most dominant and featured among other types of products that exist in the breast imaging equipment market. This can be mainly attributed to the fact that most hospitals have standardised the use of them as a screening method used to check early signs of breast cancer because recommended guidelines call on women within certain age groups to have routine mammograms.
You can also buy individual sections of this report.
Would you like to review the price list for each section?
The mammography procedure is cost-effective, non-invasive, and very efficient in mass screening, and thus it is very much in demand in the world. There is also development in digital mammography and 3D tomosynthesis that has enhanced the position of the segment in the market even more, with better accuracy and patient benefits.
Based on the application, the Breast Imaging Equipment market is classified into Screening, Diagnosis, Pre-surgical Planning, and Treatment Monitoring. The most noticeable and influential segment of the breast imaging equipment market is the screening segment of the applications. The screening is important in the early diagnosis of breast cancer, which is essential in enhancing survival and reducing the treatment expenses for patients. Across healthcare systems, regular screening, in particular mammography types of screening endeavours, is an extended activity resulting in regular demand. Screenings fulfil the role of early diagnosis and intervention, which is the root of breast imaging technology applications and the mainstream segment in the market, according to the applications.
Regional Analysis
The North American breast imaging equipment market is growing in leaps and bounds due to an ever-rising awareness of breast cancer screening and early detection. New imaging technologies, 3D mammography (tomosynthesis) and automated breast ultrasound systems become almost ubiquitous in the region. The introduction of a well-developed healthcare infrastructure on the one hand and government programmes encouraging widespread programmes of breast cancer screening on the other are beneficial to market growth.
The increasing rates of breast cancer among women and the increase in demand for non-invasive diagnostic tools of diagnosis are other factors that stimulate the market. The major players in the area are still spending resources on innovation and alliances in an attempt to improve the accuracy of the imaging procedures and the convenience for patients. Nevertheless, the high costs of equipment and reimbursement problems may curb the high market growth. North America is one of the dominant regions because of the high technology growth and healthcare policies.
The Asia-Pacific breast imaging equipment market is growing because of the awareness of breast cancer and the rising spending on healthcare. Other countries such as China, Japan, India, and Australia are spending on the use of more advanced diagnostic techniques like digital mammography, ultrasound, and MRI to enhance early detection levels. The rising government efforts concerning cancer screenings and securing a healthcare structure are the main driving forces behind market growth.
The growing occurrence of breast cancer and the growing demand for technologically enhanced, less invasive imaging solutions are making the market demand consistent. There are challenges like expensive equipment and the unavailability of skilled personnel in some sectors, which can pose a nuisance to the growth. Overall, it means that the region has great opportunities for the market players, as the population base is high and the attention to preventative care is growing.
Competitive Landscape
The breast imaging equipment market is competitive and innovation-oriented, and GE Healthcare, Hologic, Inc., Siemens Healthineers, Philips, Canon Medical Systems, and Fujifilm are major players in it. Such firms have effective portfolios on digital mammography, tomosynthesis, and ultrasound systems. Competition has been brought on in recent years by leapfrogging in AI-driven detection and automated workflow tasks. Hologic has also been able to keep expanding its presence in the market by acquiring companies, and Siemens and GE have been working to insert AI and deep learning into the imaging software to increase diagnostic accuracy.
Canon and Fujifilm emphasise compact and portable imaging devices to serve rural and destiny markets. In the meantime, newer companies such as Delphinus Medical and Micrima are making waves with their new technology, such as whole breast ultrasound and radar-based imaging. Such transformation can be described by the necessity to provide screening tools that are more available with better image qualities and the demand for early detection.
Breast Imaging Equipment Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Sample Report
Recent Developments:
- In May 2025, Hologic’s Genius AI Detection PRO mammography solution won the “Best New Imaging Technology Solution” award at the MedTech Breakthrough Awards. This AI tool helped radiologists by identifying potential cancers. It improved the accuracy of breast cancer diagnoses. The recognition highlighted its impact on advancing medical imaging.
- In May 2025, QT Imaging Holdings installed its Breast Acoustic CT scanner at Innovative Radiology in Des Moines, Iowa. The system used low-frequency sound waves to produce detailed breast images. It offered a more patient-friendly alternative to traditional imaging. This introduced a new option for breast diagnostics.
Report Coverage:
By Product
- Mammography Systems
- Breast Ultrasound Systems
- Breast MRI Systems
- Nuclear Imaging Systems
- Tomosynthesis Equipment
- Biopsy Systems
- Others
By Application
- Screening
- Diagnosis
- Pre-surgical Planning
- Treatment Monitoring
By Technology
- Ionizing Breast Imaging Technology
- Non-ionizing Breast Imaging Technology
By Modality
- Portable Devices
- Stationary Equipment
By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Specialty Clinics
- Breast Care Centers
- Academic and Research Institutes
- Post-treatment Surveillance
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Siemens AG
- Hologic, Inc.
- General Electric (GE)
- Fujifilm Holdings Corporation
- Canon Inc.
- Koninklijke Philips N.V.
- Carestream Health, Inc.
- Planmeca Group
- Dilon Technologies, Inc.
- Micrima Limited
- SonoCine, Inc.
- Delphinus Medical Technologies, Inc.
- Aurora Imaging Technology, Inc.
- Toshiba Corporation
- Analogic Corporation
Frequently Asked Questions (FAQs)
The Breast Imaging Equipment market accounted for USD 4.27 Billion in 2024 and USD 4.52 Billion in 2025 is expected to reach USD 7.99 Billion by 2035, growing at a CAGR of around 5.86% between 2025 and 2035.
Key growth opportunities in the Breast Imaging Equipment market include Expansion in emerging markets offers untapped customer base for imaging, Integration with AI enhances diagnostic precision and clinical workflow efficiency, and Increasing investments in healthcare infrastructure support equipment deployment growth.
Mammography systems are the largest segment, while breast tomosynthesis and AI-powered imaging tools are the fastest-growing in the market.
North America will make a notable contribution due to advanced healthcare infrastructure, high awareness, and early adoption of imaging technologies.
Leading players in the global breast imaging equipment market include GE Healthcare, Siemens Healthineers, Hologic, Philips Healthcare, Fujifilm, Canon Medical Systems, Planmed, Aurora, Dilon, and Carestream.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.